Literature DB >> 20493962

Inhibitory effect of human TRIM5alpha on HIV-1 production.

Xianfeng Zhang1, Mariko Kondo, Jing Chen, Hiroyuki Miyoshi, Hajime Suzuki, Takashi Ohashi, Hisatoshi Shida.   

Abstract

Tripartite motif-containing 5 isoform-alpha (TRIM5alpha), a host restriction factor, blocks infection of some retroviruses at a post-entry, pre-integration stage in a species-specific manner. A recent report by Sakuma et al. describes a second antiretroviral activity of rhesus macaque TRIM5alpha, which blocks HIV-1 production through rapid degradation of HIV-1 Gag polyproteins. Here, we find that human TRIM5alpha limits HIV-1 production. Transient expression of TRIM5alpha decreased HIV-1 production, whereas knockdown of TRIM5alpha in human cells increased virion release. A single amino acid substitution (R437C) in the SPRY domain diminished the restriction effect. Moderate levels of human wild-type TRIM5alpha and a little amount of R437C mutant were incorporated into HIV-1 virions. The R437C mutant also lost restriction activity against N-tropic murine leukemia virus infection. However, the corresponding R to C mutation in rhesus macaque TRIM5alpha had no effect on the restriction ability. Our findings suggest human TRIM5alpha is an intrinsic immunity factor against HIV-1 infection. The importance of arginine at 437 aa in SPRY domain for the late restriction is species-specific.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493962     DOI: 10.1016/j.micinf.2010.05.004

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  7 in total

1.  Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 isoforms.

Authors:  Emilie Battivelli; Julie Migraine; Denise Lecossier; Saori Matsuoka; Danielle Perez-Bercoff; Sentob Saragosti; François Clavel; Allan J Hance
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Cytoplasmic body component TRIM5{alpha} requires lipid-enriched microdomains for efficient HIV-1 restriction.

Authors:  Seiga Ohmine; Ryuta Sakuma; Toshie Sakuma; Tayaramma Thatava; Gonzalo P Solis; Yasuhiro Ikeda
Journal:  J Biol Chem       Date:  2010-09-01       Impact factor: 5.157

3.  Human TRIM5α senses and restricts LINE-1 elements.

Authors:  Bianca Volkmann; Sabine Wittmann; Justine Lagisquet; Janina Deutschmann; Kristin Eissmann; James J Ross; Brigitte Biesinger; Thomas Gramberg
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-10       Impact factor: 11.205

4.  Expression analysis of LEDGF/p75, APOBEC3G, TRIM5alpha, and tetherin in a Senegalese cohort of HIV-1-exposed seronegative individuals.

Authors:  Kim Mous; Wim Jennes; Makhtar Camara; Moussa Seydi; Géraldine Daneau; Souleymane Mboup; Luc Kestens; Xaveer Van Ostade
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

5.  Role of Human TRIM5α in Intrinsic Immunity.

Authors:  Emi E Nakayama; Tatsuo Shioda
Journal:  Front Microbiol       Date:  2012-03-15       Impact factor: 5.640

6.  Genome-wide scan for commons SNPs affecting bovine leukemia virus infection level in dairy cattle.

Authors:  Hugo A Carignano; Dana L Roldan; María J Beribe; María A Raschia; Ariel Amadio; Juan P Nani; Gerónimo Gutierrez; Irene Alvarez; Karina Trono; Mario A Poli; Marcos M Miretti
Journal:  BMC Genomics       Date:  2018-02-13       Impact factor: 3.969

7.  A Neutralization Assay Based on Pseudo-Typed Lentivirus with SARS CoV-2 Spike Protein in ACE2-Expressing CRFK Cells.

Authors:  Yalçın Pısıl; Hisatoshi Shida; Tomoyuki Miura
Journal:  Pathogens       Date:  2021-02-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.